Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
Table 1
Baseline characteristics and laboratory findings of the study population.
Characteristics
Control (n = 38)
Hypertensive (n = 49)
Age (years)
44.66 ± 7.82
44.98 ± 11.12
0.880
Gender (female/male)
30/8
17/32
0.001
SBP (mmHg)
114.5 ± 9.4
155.0 ± 13.5
0.001
DBP (mmHg)
72.6 ± 8.0
96.6 ± 10.0
0.001
Glucose (mg/dL)
95.2 ± 7.3
96.7 ± 11.9
0.501
Creatinine (mg/dL)
0.65 ± 0.13
0.85 ± 0.17
0.001
eGFR (mL/min/1.73 m2)
108.9 ± 10.8
98.94 ± 15.74
0.04
Uric acid (mg/dL)
4.37 ± 0.92
5.74 ± 1.66
0.001
Sodium (mEq/L)
140.42 ± 1.97
140.9 ± 2.52
0.235
Potassium (mEq/L)
4.46 ± 0.33
4.46 ± 0.34
0.942
Albumin (g/dL)
4.56 ± 0.4
4.66 ± 0.4
0.104
Calcium (mg/dL)
9.4 ± 0.4
9.7 ± 0.4
0.030
CRP (mg/dL)
1.37 (0.3–9.4)
2.1 (0.5–23)
0.023
Calprotectin (ng/mL)
242.8 (72.4–524)
112.6 (67.4–389.7)
0.001
SBP: systolic blood pressure; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate (was calculated using the Chronic Kidney Disease Epidemiology Collaboration); CRP: C-reactive protein. Continuous variables were reported as mean ± standard deviation or median (interquartile range), and categorical variables were reported as n. value <0.05 was significant.
